296 related articles for article (PubMed ID: 23038271)
21. Subunit-dependent inhibition and potentiation of 5-HT3 receptor by the anticancer drug, topotecan.
Nakamura Y; Ishida Y; Yamada T; Kondo M; Shimada S
J Neurochem; 2013 Apr; 125(1):7-15. PubMed ID: 23305320
[TBL] [Abstract][Full Text] [Related]
22. Palonosetron-5-HT
Price KL; Lillestol RK; Ulens C; Lummis SC
ACS Chem Neurosci; 2016 Dec; 7(12):1641-1646. PubMed ID: 27656911
[TBL] [Abstract][Full Text] [Related]
23. Natural Negative Allosteric Modulators of 5-HT₃ Receptors.
Al Kury LT; Mahgoub M; Howarth FC; Oz M
Molecules; 2018 Dec; 23(12):. PubMed ID: 30513973
[TBL] [Abstract][Full Text] [Related]
24. Unbinding pathways of an agonist and an antagonist from the 5-HT3 receptor.
Thompson AJ; Chau PL; Chan SL; Lummis SC
Biophys J; 2006 Mar; 90(6):1979-91. PubMed ID: 16387779
[TBL] [Abstract][Full Text] [Related]
25. Therapeutics of 5-HT3 receptor antagonists: current uses and future directions.
Machu TK
Pharmacol Ther; 2011 Jun; 130(3):338-47. PubMed ID: 21356241
[TBL] [Abstract][Full Text] [Related]
26. Serotonin 5-HT3 and 5-HT4 ligands: an update of medicinal chemistry research in the last few years.
Modica MN; Pittalà V; Romeo G; Salerno L; Siracusa MA
Curr Med Chem; 2010; 17(4):334-62. PubMed ID: 20015043
[TBL] [Abstract][Full Text] [Related]
27. Influence of sodium substitutes on 5-HT-mediated effects at mouse 5-HT3 receptors.
Barann M; Schmidt K; Göthert M; Urban BW; Bönisch H
Br J Pharmacol; 2004 Jun; 142(3):501-8. PubMed ID: 15148263
[TBL] [Abstract][Full Text] [Related]
28. Activation of human 5-hydroxytryptamine type 3 receptors via an allosteric transmembrane site.
Lansdell SJ; Sathyaprakash C; Doward A; Millar NS
Mol Pharmacol; 2015 Jan; 87(1):87-95. PubMed ID: 25338672
[TBL] [Abstract][Full Text] [Related]
29. The loop C region of the murine 5-HT3A receptor contributes to the differential actions of 5-hydroxytryptamine and m-chlorophenylbiguanide.
Suryanarayanan A; Joshi PR; Bikádi Z; Mani M; Kulkarni TR; Gaines C; Schulte MK
Biochemistry; 2005 Jun; 44(25):9140-9. PubMed ID: 15966738
[TBL] [Abstract][Full Text] [Related]
30. Agonists and antagonists induce different palonosetron dissociation rates in 5-HT₃A and 5-HT₃AB receptors.
Lummis SC; Thompson AJ
Neuropharmacology; 2013 Oct; 73():241-6. PubMed ID: 23747573
[TBL] [Abstract][Full Text] [Related]
31. Delineation of the functional properties and the mechanism of action of TMPPAA, an allosteric agonist and positive allosteric modulator of 5-HT3 receptors.
Gasiorek A; Trattnig SM; Ahring PK; Kristiansen U; Frølund B; Frederiksen K; Jensen AA
Biochem Pharmacol; 2016 Jun; 110-111():92-108. PubMed ID: 27086281
[TBL] [Abstract][Full Text] [Related]
32. A conserved cysteine residue in the third transmembrane domain is essential for homomeric 5-HT3 receptor function.
Wu DF; Othman NA; Sharp D; Mahendra A; Deeb TZ; Hales TG
J Physiol; 2010 Feb; 588(Pt 4):603-16. PubMed ID: 19933756
[TBL] [Abstract][Full Text] [Related]
33. Varenicline Interactions at the 5-HT3 Receptor Ligand Binding Site are Revealed by 5-HTBP.
Price KL; Lillestol RK; Ulens C; Lummis SC
ACS Chem Neurosci; 2015 Jul; 6(7):1151-7. PubMed ID: 25648658
[TBL] [Abstract][Full Text] [Related]
34. 5-HT(3) receptor expression in the mouse vestibular ganglion.
Takimoto Y; Ishida Y; Nakamura Y; Kamakura T; Yamada T; Kondo M; Kitahara T; Uno A; Imai T; Horii A; Okazaki S; Nishiike S; Inohara H; Shimada S
Brain Res; 2014 Apr; 1557():74-82. PubMed ID: 24530269
[TBL] [Abstract][Full Text] [Related]
35. Role of aspartate 298 in mouse 5-HT3A receptor gating and modulation by extracellular Ca2+.
Hu XQ; Lovinger DM
J Physiol; 2005 Oct; 568(Pt 2):381-96. PubMed ID: 16096341
[TBL] [Abstract][Full Text] [Related]
36. Binding interactions of antagonists with 5-hydroxytryptamine3A receptor models.
Maksay G; Bikádi Z; Simonyi M
J Recept Signal Transduct Res; 2003; 23(2-3):255-70. PubMed ID: 14626451
[TBL] [Abstract][Full Text] [Related]
37. A triad of residues is functionally transferrable between 5-HT
Mosesso R; Dougherty DA
J Biol Chem; 2018 Feb; 293(8):2903-2914. PubMed ID: 29298898
[TBL] [Abstract][Full Text] [Related]
38. In silico investigation into the interactions between murine 5-HT
Lohning AE; Marx W; Isenring L
J Mol Graph Model; 2016 Nov; 70():315-327. PubMed ID: 27816008
[TBL] [Abstract][Full Text] [Related]
39. Bupropion Inhibits Serotonin Type 3AB Heteromeric Channels at Clinically Relevant Concentrations.
Stuebler AG; Jansen M
Mol Pharmacol; 2020 Mar; 97(3):171-179. PubMed ID: 31871303
[TBL] [Abstract][Full Text] [Related]
40. Investigation of 5-HT
Kojima SI; Kojima K; Fujita T
Eur J Pharmacol; 2017 Mar; 799():196-200. PubMed ID: 28189582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
